Assessment Monitoring of Laboratory Critical Values: A College of American Pathologists Q-Tracks Study of 180 Institutions

2007 ◽  
Vol 131 (1) ◽  
pp. 44-49 ◽  
Author(s):  
Elizabeth A. Wagar ◽  
Ana K. Stankovic ◽  
David S. Wilkinson ◽  
Molly Walsh ◽  
Rhona J. Souers

Abstract Context.—Critical laboratory value reporting is a highly visible and essential key activity for clinical laboratories. Objective.—To measure critical laboratory value reporting in multiple institutions over time and to examine the practice patterns and demographic factors associated with sustained improvement in critical value reporting. Design.—A longitudinal cohort study of 180 clinical laboratories that provided quarterly critical values reporting data for 2 to 16 quarters was conducted using a uniform definition of successful caregiver notification. Mixed linear model analysis of the 2001 through 2004 dataset was performed. Results.—A decrease in total and inpatient rates of undocumented critical values per 1000 results was associated with (1) the American Association of Blood Banks inspection within the past 2 years (P = .01, for both total and inpatient rates); (2) unit secretary/clerical staff not authorized to accept inpatient critical value notification (P = .004 [total] and .001 [inpatient]); and (3) the mandatory practice of requiring notification of health care providers when handling inpatients known to have results repeatedly in the critical range (P = .01, for both total and inpatient rates). Continued participation in the Q-Tracks monitoring program was associated with significant and progressive improvement in total, inpatient, and outpatient critical value reporting (P = .02, .01, and .003, respectively). Conclusions.—Critical value reporting improved as the duration of participation in the Q-Tracks monitoring program increased. Improved total and inpatient critical value reporting was associated with factors that may be markers for institutions with priorities of quality management and enhanced communication with responsible caregivers.

2018 ◽  
Vol 36 (5) ◽  
pp. 436-446 ◽  
Author(s):  
Pamela Durepos ◽  
Tamara Sussman ◽  
Jenny Ploeg ◽  
Noori Akhtar-Danesh ◽  
Harveer Punia ◽  
...  

Purpose: The purpose of this study was to clarify the concept of death preparedness for family caregivers in dementia. Conceptualization was required to support the assessment, promotion, and operationalization (ie, measurement) of death preparedness through palliative care interventions such as advance care planning. Methods: Rodgers evolutionary method of concept analysis was selected to guide this study because of the dynamic nature of death preparedness influenced by context, setting, and time. A comprehensive literature search was conducted. Authors performed constant comparative analysis to identify and interpret surrogate/related concepts, attributes, antecedents, and consequences of death preparedness. Results: Most importantly attributes included (1) knowing and recognizing the symptoms of decline in dementia and what dying looks like; (2) understanding emotions and grief responses; (3) accessing and appraising supports needed to manage and care for dying; (4) organizing affairs and completing tasks in advance; (5) accepting that losses are inevitable and imminent; (6) reflecting on caregiving and finding meaning, “a silver-lining”; and (7) closing, reconciling, and renewing relationship bonds and completing the family member’s life. Discussion: This study contributed a full definition of death preparedness in dementia. Findings aligned with/expanded upon Hebert et al Theoretical Framework of Preparedness for End-of-Life. The use of problem- and emotion-based coping strategies by caregivers with support from health-care providers to promote feelings of death preparedness (including self-efficacy and control) and minimize uncertainty was the implication of this study. Development of a holistic preparedness instrument is underway.


2012 ◽  
Vol 19 (5) ◽  
pp. 608-618 ◽  
Author(s):  
Shigeko (Seiko) Izumi ◽  
Hiroko Nagae ◽  
Chihoko Sakurai ◽  
Emiko Imamura

Despite increasing interests and urgent needs for quality end-of-life care, there is no exact definition of what is the interval referred to as end of life or what end-of-life care is. The purpose of this article is to report our examination of terms related to end-of-life care and define end-of-life care from nursing ethics perspectives. Current terms related to end-of-life care, such as terminal care, hospice care, and palliative care, are based on a medical model and are restrictive in terms of diagnosis and prognosis. Using codes of ethics for nurses as a framework, we attempt to identify people to whom nurses are responsible to provide end-of-life care and develop a definition of end-of-life care that is more inclusive and applicable to a broader range of people who would benefit from end-of-life care by nurses and other health-care providers.


2013 ◽  
Vol 712-715 ◽  
pp. 3203-3206
Author(s):  
Hong Wang ◽  
Ying Chang ◽  
Wen Sheng Che

Objective: Through the PDCA (Plan-Do-Check-Act, also called quality loop) cycle in the management of Critical Value Reporting, and then the discussion on the values of their application in the medical field. Methods: Data were divided into two groups (January to March in 2012 as before the implementation of PDCA-cycle and August to October as after the implementation of PDCA-cycle). Statistical analysis was applied for these two groups. Results: After the application of PDCA-cycle, the executing rate of critical values reporting increased from 38.2% to 96.4 % (P=0.000). The percentage of reporting time, repeat critical values reporting, reporters name and staff number, receivers name and staff number rised from 96.4%, 83.6%, 83.6%, 69.1% to 100.0%, 98.8%, 98.8%, 99.8%, respectively (P=0.000). Meanwhile, critical values reporting rate of Laboratory and Radiology also increased from 47.9%, 30.6% to 96.5%, 96.3% (P=0.000). Conclusion: This study suggested that the PDCA-cycle is an important tool for quality management, and it can effectively improve the executions of critical values reporting.


2021 ◽  
Vol 12 (1) ◽  
pp. 248-253
Author(s):  
Bothiraj M ◽  
Alagusundaram M ◽  
Chandra Sekhar K B

Pharmacoepidemiology deals with the use and effects of medications in a large number of population—the combination of epidemiology principles to the effects of drug and its usage. Pharmacoepidemiology helps in optimal utilization of medicines and assist health care providers in making better decisions on drug therapy that will tend to curtail the Drug-Drug interactions, thereby prevents alteration in the pharmacological activity of one drug by another. Among all types of interaction, Drug-Drug interaction causes a higher rate of mortality. A prospective study conducted with 653 prescriptions that were collected from the various regions of Andhra Pradesh like Kadapa, Proddatur, Pulivendula, Kurnool are checked in interaction checker, results are projected in 4 categories a) Age and Sex preponderance(Demographics) rate of drugs interaction b) Interaction rate of major/minor type c) Department wise - General medicine (72.37%), Gynaec (69.02%), Pediatric (29.33%), Ophthalmology (75%) d) Most common interacting pairs of various department Ex: Ceftriaxone & Furosemide, Diclofenac & Furosemide, Albuterol & Losartan are observed in General Medicine. Statistical significance (P-value 0.00002) is obtained based on One Way ANOVA. This study elucidates the significance of pharmacoepidemiology; however, this requires much efforts to prevent causation effects of drugs. It is helpful to locate them by the establishment of “Drug interaction monitoring program” or by establishing “Pharmacoepidemiological centres” in every hospital for the screening of prescriptions by “Pharmacist” and thereby edify doctors and public for better medication use.


2007 ◽  
Vol 131 (12) ◽  
pp. 1769-1775 ◽  
Author(s):  
Elizabeth A. Wagar ◽  
Richard C. Friedberg ◽  
Rhona Souers ◽  
Ana K. Stankovic

Abstract Context.—Critical laboratory values are values that may be indicative of life-threatening conditions requiring rapid clinical intervention. Designation of critical values by clinical laboratories is required by the Clinical Laboratory Improvement Amendments and regulatory agencies. The development of critical values often involves consultation with clinical services. Also, questions are frequently asked about how critical values compare between institutions. Objective.—To examine and compare critical value ranges for selected common critical value analytes. Additional specific questions addressed the source of these values, the inclusion of specific items on a critical values list, and the procedures for establishing such lists. Design.—A total of 163 clinical laboratories provided critical values for potassium, calcium, magnesium, thyroid-stimulating hormone, hemoglobin, platelet count, and activated partial thromboplastin time. Collected data were subjected to analysis for statistical variation. A questionnaire regarding demographic characteristics, institutional practices, and critical values management was also completed by participants. Results.—There was slight variation in pediatric and adult critical values used by the central 80% of study laboratories. Three areas of interest were noted: (1) 27% of laboratories allowed nonpractitioners to accept inpatient critical value reports, (2) there was nonconsensus regarding the handling of outpatient critical values during weekday versus evening/weekend hours, and (3) only 56% of respondents had a written critical values policy or procedure. Conclusions.—Pediatric and adult critical values for the selected analytes were consistent in a comparison between the 163 clinical laboratories. Several weaknesses in current critical values management were identified. A consensus critical values list that may be of value to other institutions was assembled.


2005 ◽  
Vol 129 (10) ◽  
pp. 1222-1225 ◽  
Author(s):  
Leonas G. Bekeris ◽  
Joseph A. Tworek ◽  
Molly K. Walsh ◽  
Paul N. Valenstein

Abstract Context.—Blood culture contamination extends hospital stays and increases the cost of care. Objectives.—To measure blood culture contamination rates in a large number of institutions over time and to elucidate practice patterns and demographic factors associated with sustained reduction in contamination rates. Design.—Longitudinal cohort study of 356 clinical laboratories that provided quarterly data about blood culture results, using a uniform definition of contamination. Mixed linear model analysis of the 1999 through 2003 data set. Results.—Blood culture contamination was significantly higher in institutions that used nonlaboratory personnel to collect blood (P = .03) and significantly lower in facilities that used a dedicated phlebotomy team (P < .001). Higher volume of blood collection was significantly associated with lower contamination rates (P < .001). Continued participation in the Q-Tracks monitoring program was associated with significant and progressive reduction in contamination rates. By the fifth year of participation, the median institution had reduced its blood culture contamination rate by 0.67% (P < .001). Conclusions.—Institutions that use decentralized patient-centered personnel rather than dedicated phlebotomy teams to collect blood cultures experience significantly higher contamination rates. Long-term monitoring of contamination is associated with sustained improvement in performance.


2008 ◽  
Vol 132 (10) ◽  
pp. 1666-1671
Author(s):  
Anand S. Dighe ◽  
Jay B. Jones ◽  
Sue Parham ◽  
Kent B. Lewandrowski

Abstract Context.—Reporting of laboratory critical values has become an issue of national attention because of important regulatory, medicolegal, and clinical concerns. Objective.—To survey aspects of the laboratory critical-value reporting process at a broad range of institutions. Design.—A survey was developed regarding the operational and information-technology aspects of critical value reporting. Results.—More than 730 responses were obtained from a broad distribution of hospitals. In addition, we analyzed more than 700 written responses from survey participants. Conclusions.—The survey results provide insight into the standard of practice and level of compliance with current Joint Commission and College of American Pathologists requirements for critical values, demonstrate considerable heterogeneity, and suggest areas for improvement. A common issue raised during the survey and follow-up teleconference was the incidence of outpatient false-positive critical values. In this report, we also demonstrate that attention to preanalytic transport and processing issues can assist in minimizing this issue.


2008 ◽  
Vol 7 (3) ◽  
pp. 159-171 ◽  
Author(s):  
Cher Kinamore

AbstractBackground: Breast cancer is the most common cancer and most common cancer cause of death in women aged 20–49 years in Canada. Developing a functional definition of ‘young’ is imperative in assessing and providing appropriate emotional support to the unique body image and sexuality concerns facing ‘young’ women with breast cancer. These concerns require proper assessment in order to provide appropriate interventions.Aims and objectives: To seek a functional definition of ‘young’ and to determine what body image and sexuality assessment tools and interventions are the most appropriate for young women with breast cancer.Methods: A literature search was undertaken to determine what body image and sexuality assessment tools and interventions are available and relevant to young women with breast cancer. Also, the assessment and interventions available to this patient cohort in the author's clinic were explored.Conclusions: Body image and sexuality questionnaires encourage young women and health-care providers (HCPs) to openly discuss these issues. Annon's PLISSIT model is an assessment and intervention strategy that enables HCPs to adequately assess and refer young women to suitable programs such as support groups and counsellors. The multi-disciplinary team should provide continuous emotional assessment and support throughout the cancer journey by collaborating to develop the best interventional strategies to the patient and her family.


Epilepsia ◽  
2005 ◽  
Vol 46 (5) ◽  
pp. 743-750 ◽  
Author(s):  
Krishnan Anand ◽  
Satish Jain ◽  
Eldho Paul ◽  
Achal Srivastava ◽  
Sirazul A. Sahariah ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document